What Diseases Will WellDoc Tackling Next?

Read Transcript

I think it's a couple of vectors of expansion. Certainly other diseases like I just said, we always call it the triangle of death that has diabetes in the middle that has hypertension, high blood pressure, hyperlipidemia, high cholesterol and obesity. And if you can manage that triangle, you are doing human service to society.

But then beyond that you have respiratory, asthma, COPD, you have heart, CBD, CHF, and then you have things like the autoimmune diseases, lupus, rheumatoid arthritis, psoriasis and all of these solutions can benefit, oncology all these solutions can benefit. So there is a vector that says expand disease state and in fact regardless of the disease state you still need to manage those four things.

Life style, metabolics, medication and symptoms. The content changes the rules change but it's the same four pillars, so that's one vector. The second vector is clearly where you take it in the world, this is not a US problem we are focusing on the US of A. We've had a lot of draw and interests from a number of countries and their governments around the world.

The 3rd vector goes back to your comment which is about engagement and making it simple, the whole world of sensor integration, if you can get some of this data without bothering the patient and it just gets, you start to think about some of the great work that people like Sunnyboo/g and Mystique Wearables/g are doing.

If you get data that just innocuously comes into the system, that helps manage and creates, that's interesting all of a sudden the system tells you something and you didn't even know was happening. I think those types of things being, that's our job, is to create that technology fabric in the background to make it as simple and as least disruptive to daily life for the patient and the physician I think those are three very interesting vectors of expansion.